abrdn Life Sciences Investors Stock Price, News & Analysis
HQL
NYSE
Company Description
Welcome to the overview page for abrdn Life Sciences Investors (HQL), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Insider Radar
90-Day Summary
7,923
Shares Bought
0
Shares Sold
1
Transactions
Most Recent Transaction
Pittard Christian
(Director)
bought
7,923 shares
@ $16.88
on Dec 16, 2025
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of abrdn Life Sciences Investors (HQL)?
The current stock price of abrdn Life Sciences Investors (HQL) is $17.17 as of February 3, 2026.
What is the market cap of abrdn Life Sciences Investors (HQL)?
The market cap of abrdn Life Sciences Investors (HQL) is approximately 507.9M. Learn more about what market capitalization means .